FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Animals (Basel) / Shipping Temperature, Time and Media Effects on Equine Whart...
Animals : an open access journal from MDPI2022; 12(15); doi: 10.3390/ani12151967

Shipping Temperature, Time and Media Effects on Equine Wharton’s Jelly and Adipose Tissue Derived Mesenchymal Stromal Cells Characteristics.

Abstract: To use Mesenchymal Stromal Cells (MSCs) in equine patients, isolation and expansion are performed in a laboratory. Cells are then sent back to the veterinary clinic. The main goal of storage conditions during cell transport is to preserve their biological properties and viability. The aim of this study was to evaluate the effects of storage solutions, temperature and time on the characteristics of equine adipose tissue and Wharton's jelly-derived MSCs. We compared two different storage solutions (plasma and 0.9% NaCl), two different temperatures (4 °C and room temperature) and three time frames (6, 24, 48 h). Cell viability, colony-forming units, trilineage differentiation, the expression of CD45 and CD90 antigens and adhesion potentials were evaluated. Despite the molecular characterization and differentiation potential were not influenced by storage conditions, viability, colony-forming units and adhesion potential are influenced in different way, depending on MSCs sources. Overall, this study found that, despite equine adipose tissue MSCs being usable after 24 h of storage, cells derived from Wharton's jelly need to be used within 6 h. Moreover, while for adipose cells the best conservation solutions seems to be plasma, the cell viability of Wharton's jelly MSCs declined in both saline and plasma solution, confirming their reduced resistance to conservation.
Get Full Text
Publication Date: 2022-08-03 PubMed ID: 35953956PubMed Central: PMC9367575DOI: 10.3390/ani12151967Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study investigates the impact of storage solutions, temperature, and duration on the quality of Mesenchymal Stromal Cells (MSCs) derived from equine fat tissue and Wharton’s jelly. The findings suggest that these cells can be effectively used within 24 hours if preserved in plasma, while those from Wharton’s jelly need to be used within 6 hours, regardless of the type of solution they are stored in.

Research Objectives and Approach

  • The study aimed to explore the effects of storage conditions on the properties and viability of Equine Mesenchymal Stromal Cells (MSCs) sourced from adipose tissue and Wharton’s jelly – a gelatinous substance in the umbilical cord.
  • Researchers compared the impact of two different storage solutions on the cells: plasma and saline (0.9% Sodium Chloride, NaCl), two temperature settings (4 degrees Celsius and room temperature), and three time durations (6, 24, and 48 hours).

MSCs Characteristics Evaluated

  • The viability of the cells was assessed to gauge the fraction of vivo (live) cells after storage.
  • The ability to form colony-forming units was evaluated. The capacity to form these units gives an indication of the number of individual cells, initially present, that can proliferate and develop into colonies.
  • The trilineage differentiation capacity was looked at to distinguish their potential to differentiate into three essential lineages: osteoblastic (bone cells), adipogenic (fat cells), and chondrogenic (cartilage cells).
  • The expressions of CD45 and CD90 antigens were assessed. The CD45 antigen is usually present on the surface of all white blood cells, and it’s absence in MSCs typically indicates their non-hematopoietic origin. On the other hand, CD90 is a marker widely found on the surface of MSCs.
  • The adhesion potential of the cells was evaluated for understanding the cells’ capability to stick onto surfaces or with each other.

Key Findings

  • The molecular characteristics and differentiation potential of these cells were found unaffected by the storage conditions.
  • However, cell viability, potential to form colony units, and adhesive capability were impacted, in different ways, based on the source of the MSCs.
  • Adipose tissue-derived MSCs maintained their usability up to 24 hours of storage, especially when preserved in plasma. However, MSCs from Wharton’s jelly need to be used within a time frame of 6 hours, irrespective of the preservation solution used.
  • The study confirmed the sensitivity of Wharton’s jelly-derived MSCs to preservation conditions, as indicated by their declining viability in both saline and plasma solutions.

Cite This Article

APA
Iacono E, Lanci A, Gugole P, Merlo B. (2022). Shipping Temperature, Time and Media Effects on Equine Wharton’s Jelly and Adipose Tissue Derived Mesenchymal Stromal Cells Characteristics. Animals (Basel), 12(15). https://doi.org/10.3390/ani12151967

Publication

Animals : an open access journal from MDPI
ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 12
Issue: 15

Researcher Affiliations

Iacono, Eleonora
  • Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, Ozzano Emilia, 40064 Bologna, Italy.
  • Interdepartmental Centre for Industrial Research in Health Sciences and Technologies, University of Bologna, Via Tolara di Sopra 41/E, Ozzano Emilia, 40064 Bologna, Italy.
Lanci, Aliai
  • Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, Ozzano Emilia, 40064 Bologna, Italy.
Gugole, Penelope
  • Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, Ozzano Emilia, 40064 Bologna, Italy.
Merlo, Barbara
  • Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, Ozzano Emilia, 40064 Bologna, Italy.
  • Interdepartmental Centre for Industrial Research in Health Sciences and Technologies, University of Bologna, Via Tolara di Sopra 41/E, Ozzano Emilia, 40064 Bologna, Italy.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 24 references
  1. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells.. Cytokine Growth Factor Rev 2009 Oct-Dec;20(5-6):419-27.
    doi: 10.1016/j.cytogfr.2009.10.002pubmed: 19926330google scholar: lookup
  2. Barrachina L, Romero A, Zaragoza P, Rodellar C, Vázquez FJ. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.. Vet J 2018 Aug;238:49-57.
    doi: 10.1016/j.tvjl.2018.07.004pubmed: 30103915google scholar: lookup
  3. Iacono E, Merlo B, Romagnoli N, Rossi B, Ricci F, Spadari A. Equine Bone Marrow and Adipose Tissue Mesenchymal Stem Cells: Cytofluorimetric Characterization, In Vitro Differentiation, and Clinical Application. J. Equine Vet. Sci. 2015;35:130–140.
    doi: 10.1016/j.jevs.2014.12.010google scholar: lookup
  4. Colleoni S, Bottani E, Tessaro I, Mari G, Merlo B, Romagnoli N, Spadari A, Galli C, Lazzari G. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor.. Vet Res Commun 2009 Dec;33(8):811-21.
    doi: 10.1007/s11259-009-9229-0pubmed: 19472068google scholar: lookup
  5. Lange-Consiglio A, Tassan S, Corradetti B, Meucci A, Perego R, Bizzaro D, Cremonesi F. Investigating the efficacy of amnion-derived compared with bone marrow-derived mesenchymal stromal cells in equine tendon and ligament injuries.. Cytotherapy 2013 Aug;15(8):1011-20.
    doi: 10.1016/j.jcyt.2013.03.002pubmed: 23602577google scholar: lookup
  6. Iacono E, Merlo B, Pirrone A, Antonelli C, Brunori L, Romagnoli N, Castagnetti C. Effects of mesenchymal stem cells isolated from amniotic fluid and platelet-rich plasma gel on severe decubitus ulcers in a septic neonatal foal.. Res Vet Sci 2012 Dec;93(3):1439-40.
    doi: 10.1016/j.rvsc.2012.04.008pubmed: 22579411google scholar: lookup
  7. Corradetti B, Correani A, Romaldini A, Marini MG, Bizzaro D, Perrini C, Cremonesi F, Lange-Consiglio A. Amniotic membrane-derived mesenchymal cells and their conditioned media: potential candidates for uterine regenerative therapy in the horse.. PLoS One 2014;9(10):e111324.
    doi: 10.1371/journal.pone.0111324pmc: PMC4216086pubmed: 25360561google scholar: lookup
  8. Lanci A, Merlo B, Mariella J, Castagnetti C, Iacono E. Heterologous Wharton's Jelly Derived Mesenchymal Stem Cells Application on a Large Chronic Skin Wound in a 6-Month-Old Filly.. Front Vet Sci 2019;6:9.
    doi: 10.3389/fvets.2019.00009pmc: PMC6363668pubmed: 30761313google scholar: lookup
  9. Lange-Consiglio A, Funghi F, Cantile C, Idda A, Cremonesi F, Riccaboni P. Case Report: Use of Amniotic Microvesicles for Regenerative Medicine Treatment of a Mare With Chronic Endometritis.. Front Vet Sci 2020;7:347.
    doi: 10.3389/fvets.2020.00347pmc: PMC7311574pubmed: 32626730google scholar: lookup
  10. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. Isolation of amniotic stem cell lines with potential for therapy.. Nat Biotechnol 2007 Jan;25(1):100-6.
    doi: 10.1038/nbt1274pubmed: 17206138google scholar: lookup
  11. Merlo B, Teti G, Lanci A, Burk J, Mazzotti E, Falconi M, Iacono E. Comparison between adult and foetal adnexa derived equine post-natal mesenchymal stem cells.. BMC Vet Res 2019 Aug 2;15(1):277.
    doi: 10.1186/s12917-019-2023-5pmc: PMC6679462pubmed: 31375144google scholar: lookup
  12. Iacono E, Pascucci L, Rossi B, Bazzucchi C, Lanci A, Ceccoli M, Merlo B. Ultrastructural characteristics and immune profile of equine MSCs from fetal adnexa.. Reproduction 2017 Oct;154(4):509-519.
    doi: 10.1530/REP-17-0032pubmed: 28733347google scholar: lookup
  13. Becerra P, Valdés Vázquez MA, Dudhia J, Fiske-Jackson AR, Neves F, Hartman NG, Smith RK. Distribution of injected technetium(99m)-labeled mesenchymal stem cells in horses with naturally occurring tendinopathy.. J Orthop Res 2013 Jul;31(7):1096-102.
    doi: 10.1002/jor.22338pubmed: 23508674google scholar: lookup
  14. Garvican ER, Cree S, Bull L, Smith RK, Dudhia J. Viability of equine mesenchymal stem cells during transport and implantation.. Stem Cell Res Ther 2014 Aug 8;5(4):94.
    doi: 10.1186/scrt483pmc: PMC4247703pubmed: 25107289google scholar: lookup
  15. Bronzini I, Patruno M, Iacopetti I, Martinello T. Influence of temperature, time and different media on mesenchymal stromal cells shipped for clinical application.. Vet J 2012 Oct;194(1):121-3.
    doi: 10.1016/j.tvjl.2012.03.010pubmed: 22503718google scholar: lookup
  16. Mercati F, Pascucci L, Curina G, Scocco P, Tardella FM, Dall'aglio C, Marini C, Ceccarelli P. Evaluation of storage conditions on equine adipose tissue-derived multipotent mesenchymal stromal cells.. Vet J 2014 May;200(2):339-42.
    doi: 10.1016/j.tvjl.2014.02.018pubmed: 24656629google scholar: lookup
  17. Espina M, Jülke H, Brehm W, Ribitsch I, Winter K, Delling U. Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses.. PeerJ 2016;4:e1773.
    doi: 10.7717/peerj.1773pmc: PMC4806605pubmed: 27019778google scholar: lookup
  18. Merlo B, Pirondi S, Iacono E, Rossi B, Ricci F, Mari G. VIABILITY, IN VITRO DIFFERENTIATION AND MOLECULAR CHARACTERIZATION OF EQUINE ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS CRYOPRESERVED IN SERUM AND SERUM-FREE MEDIUM.. Cryo Letters 2016 Jul Aug;37(4):243-252.
    pubmed: 27925007
  19. Mizuno H, Hyakusoku H. Mesengenic potential and future clinical perspective of human processed lipoaspirate cells.. J Nippon Med Sch 2003 Aug;70(4):300-6.
    doi: 10.1272/jnms.70.300pubmed: 12928709google scholar: lookup
  20. Iacono E, Brunori L, Pirrone A, Pagliaro PP, Ricci F, Tazzari PL, Merlo B. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse.. Reproduction 2012 Apr;143(4):455-68.
    doi: 10.1530/REP-10-0408pubmed: 22274885google scholar: lookup
  21. Mohanty N, Gulati BR, Kumar R, Gera S, Kumar P, Somasundaram RK, Kumar S. Immunophenotypic characterization and tenogenic differentiation of mesenchymal stromal cells isolated from equine umbilical cord blood.. In Vitro Cell Dev Biol Anim 2014 Jun;50(6):538-48.
    doi: 10.1007/s11626-013-9729-7pubmed: 24414976google scholar: lookup
  22. Desmarais JA, Demers SP, Suzuki J Jr, Laflamme S, Vincent P, Laverty S, Smith LC. Trophoblast stem cell marker gene expression in inner cell mass-derived cells from parthenogenetic equine embryos.. Reproduction 2011 Mar;141(3):321-32.
    doi: 10.1530/REP-09-0536pubmed: 21209071google scholar: lookup
  23. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    doi: 10.1080/14653240600855905pubmed: 16923606google scholar: lookup
  24. Ling L, Camilleri ET, Helledie T, Samsonraj RM, Titmarsh DM, Chua RJ, Dreesen O, Dombrowski C, Rider DA, Galindo M, Lee I, Hong W, Hui JH, Nurcombe V, van Wijnen AJ, Cool SM. Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells.. Gene 2016 Jan 15;576(1 Pt 2):292-303.
    doi: 10.1016/j.gene.2015.10.039pmc: PMC5330685pubmed: 26484394google scholar: lookup

Citations

This article has been cited 4 times.
  1. Iacono E, Merlo B. Stem Cells in Domestic Animals: Applications in Health and Production. Animals (Basel) 2022 Oct 13;12(20).
    doi: 10.3390/ani12202753pubmed: 36290139google scholar: lookup
  2. Kilbride P. Cold Chain Delivery in Cell Therapies. Adv Exp Med Biol 2025;1486:295-302.
    doi: 10.1007/978-3-031-97297-3_22pubmed: 41136848google scholar: lookup
  3. Capone A, Merlo B, Begni F, Iacono E. Equine Colostrum-Derived Mesenchymal Stromal Cells: A Potential Resource for Veterinary Regenerative Medicine. Vet Sci 2025 Jul 19;12(7).
    doi: 10.3390/vetsci12070681pubmed: 40711341google scholar: lookup
  4. Andreoli V, Berni P, Conti V, Ramoni R, Basini G, Grolli S. Mesenchymal Stromal Cells Derived from Canine Adipose Tissue: Evaluation of the Effect of Different Shipping Vehicles Used for Clinical Administration. Int J Mol Sci 2024 Mar 18;25(6).
    doi: 10.3390/ijms25063426pubmed: 38542399google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.